Chongqing aoli biopharmaceutical co., ltd. has a unified social credit code/registration number of 915001kloc-0/709485279t, and the enterprise is in the opening state.
The business scope of Chongqing Aoli Biopharmaceutical Co., Ltd. is: production: tablets, hard capsules, raw materials (pancreatin, pepsin, gastrin, chondroitin sulfate sodium). Engaged in the export business of self-produced products of this enterprise; Engaged in the import business of raw and auxiliary materials needed for the production of this enterprise (except for commodities whose import and export are restricted or prohibited by the state). Processing and sales of biochemical products (excluding biopharmaceuticals and products) [except for projects that require pre-approval or approval as stipulated by laws, administrative regulations and the State Council decisions]. In Chongqing, the total registered capital of companies with similar business scope is 4,833.09 million yuan, and the main capital is concentrated in 24 enterprises with a scale of more than 50 million. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
See more information and materials of Chongqing Aoli Biopharmaceutical Co., Ltd. through Baidu Enterprise Credit.